{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:42:58Z","timestamp":1793727778740,"version":"4.6.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100017542","name":"Beijing Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371359"],"award-info":[{"award-number":["82371359"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.cca.2025.120584","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T23:01:38Z","timestamp":1756767698000},"page":"120584","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Serum GPR37 as a novel biomarker for disease activity, disability, and differential diagnosis in NMOSD"],"prefix":"10.1016","volume":"578","author":[{"given":"Xiaotong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wencan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaowei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhui","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengwen","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haihong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4911-5784","authenticated-orcid":false,"given":"Guojun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2025.120584_b0005","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/cns.13836","article-title":"Progress in treatment of neuromyelitis optica spectrum disorders (NMOSD): novel insights into therapeutic possibilities in NMOSD","volume":"28","author":"Shi","year":"2022","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.cca.2025.120584_b0010","doi-asserted-by":"crossref","first-page":"5875","DOI":"10.1007\/s00415-024-12527-6","article-title":"Spinal movement disorders in NMOSD, MOGAD, and idiopathic transverse myelitis: a prospective observational study","volume":"271","author":"Abboud","year":"2024","journal-title":"J. Neurol."},{"key":"10.1016\/j.cca.2025.120584_b0015","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.1007\/s00415-024-12452-8","article-title":"Sex ratio and age of onset in AQP4 antibody-associated NMOSD: a review and meta-analysis","volume":"271","author":"Arnett","year":"2024","journal-title":"J. Neurol."},{"key":"10.1016\/j.cca.2025.120584_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2025.103761","article-title":"Differences in clinical phenotype, laboratory, and imaging manifestations between AQP4 IgG positive and AQP4 MOG IgG double negative NMOSD: how to correctly diagnose the two","volume":"24","author":"Chu","year":"2025","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.cca.2025.120584_b0025","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/brain\/awad373","article-title":"Interferon-\u03b3 controls aquaporin 4-specific Th17 and B cells in neuromyelitis optica spectrum disorder","volume":"147","author":"Arellano","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.cca.2025.120584_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103465","article-title":"A comprehensive review of the advances in neuromyelitis optica spectrum disorder","volume":"22","author":"Siriratnam","year":"2023","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.cca.2025.120584_b0035","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/WCO.0000000000001128","article-title":"Optic neuritis: current challenges in diagnosis and management","volume":"36","author":"Benard-Seguin","year":"2023","journal-title":"Curr. Opin. Neurol."},{"issue":"8","key":"10.1016\/j.cca.2025.120584_b0040","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/jama.2020.26858","article-title":"Diagnosis and Treatment of Multiple Sclerosis: a Review","volume":"325","author":"McGinley","year":"2021","journal-title":"JAMA"},{"issue":"Suppl 6","key":"10.1016\/j.cca.2025.120584_b0045","doi-asserted-by":"crossref","first-page":"s53","DOI":"10.7861\/clinmedicine.16-6-s53","article-title":"Multiple sclerosis, a treatable disease","volume":"16","author":"Doshi","year":"2016","journal-title":"Clin. Med. (Lond.)"},{"issue":"10076","key":"10.1016\/j.cca.2025.120584_b0050","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/S0140-6736(16)30959-X","article-title":"Diagnosis of multiple sclerosis: progress and challenges","volume":"389","author":"Brownlee","year":"2017","journal-title":"Lancet (London, England)"},{"issue":"6","key":"10.1016\/j.cca.2025.120584_b0055","article-title":"Toward precision phenotyping of multiple sclerosis","volume":"9","author":"Pitt","year":"2022","journal-title":"Neurology(r) Neuroimmunol. Neuroinflamm."},{"issue":"7","key":"10.1016\/j.cca.2025.120584_b0060","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1007\/s00415-023-11634-0","article-title":"Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) \u2013 revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: diagnosis and differential diagnosis","volume":"270","author":"Jarius","year":"2023","journal-title":"J. Neurol."},{"key":"10.1016\/j.cca.2025.120584_b0065","doi-asserted-by":"crossref","first-page":"10932","DOI":"10.3390\/ijms241310932","article-title":"Brain-biomarker changes in body fluids of patients with Parkinson\u2019s disease","volume":"24","author":"Cocco","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2025.120584_b0070","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abi5811","article-title":"Osteocalcin attenuates oligodendrocyte differentiation and myelination via GPR37 signaling in the mouse brain","volume":"7","author":"Qian","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.cca.2025.120584_b0075","doi-asserted-by":"crossref","first-page":"10884","DOI":"10.1038\/ncomms10884","article-title":"G protein-coupled receptor 37 is a negative regulator of oligodendrocyte differentiation and myelination","volume":"7","author":"Yang","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cca.2025.120584_b0080","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1021\/acschemneuro.3c00479","article-title":"Orphan G protein-coupled receptor GPR37 as an emerging therapeutic target","volume":"14","author":"Bolinger","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.cca.2025.120584_b0085","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuroscience.2017.06.006","article-title":"Mice lacking Gpr37 exhibit decreased expression of the myelin-associated glycoprotein MAG and increased susceptibility to demyelination","volume":"358","author":"Smith","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.cca.2025.120584_b0090","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.lfs.2019.03.045","article-title":"The role of orphan G protein-coupled receptors in the pathophysiology of multiple sclerosis: a review","volume":"224","author":"Alavi","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.cca.2025.120584_b0095","doi-asserted-by":"crossref","first-page":"9529","DOI":"10.1073\/pnas.1219004110","article-title":"GPR37 and GPR37L1 are receptors for the neuroprotective and glioprotective factors prosaptide and prosaposin","volume":"110","author":"Meyer","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"7","key":"10.1016\/j.cca.2025.120584_b0100","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.3390\/ijms23074028","article-title":"Emerging roles for the orphan GPCRs, GPR37 and GPR37 L1, in stroke pathophysiology","volume":"23","author":"Mouhi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2025.120584_b0105","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.cca.2025.120584_b0110","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1212\/WNL.0000000000002366","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"86","author":"Tan","year":"2016","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.cca.2025.120584_b0115","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16365","article-title":"Guillain-Barr\u00e9 syndrome: a comprehensive review","volume":"31","author":"Bellanti","year":"2024","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.cca.2025.120584_b0120","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2024.1474043","article-title":"Alzheimer's disease: a comprehensive review of epidemiology, risk factors, symptoms diagnosis, management, caregiving, advanced treatments and associated challenges","volume":"11","author":"Safiri","year":"2024","journal-title":"Front. Med."},{"issue":"6","key":"10.1016\/j.cca.2025.120584_b0125","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11910-024-01339-w","article-title":"Epidemiology of Parkinson's disease: an update","volume":"24","author":"Deliz","year":"2024","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.cca.2025.120584_b0130","unstructured":"X. Montalban, Revisions of the McDonald criteria, in: ECTRIMS: 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, 2024, pp. 18\u201320. September 2024. Accessed 5 November 2024, https:\/\/ectrims.eu\/mcdonald-diagnostic-criteria."},{"key":"10.1016\/j.cca.2025.120584_b0135","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/j.jtho.2020.11.030","article-title":"Using propensity score matching to balance the baseline characteristics","volume":"16","author":"Liang","year":"2021","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.cca.2025.120584_b0140","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209940","article-title":"for MSBase, Prevalence of progression independent of relapse activity and relapse-associated worsening in patients with AQP4-IgG-positive NMOSD","volume":"103","author":"Siriratnam","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.cca.2025.120584_b0145","doi-asserted-by":"crossref","first-page":"10065","DOI":"10.2147\/JIR.S489502","article-title":"Inflammatory and nutritional markers as indicators for diagnosing and assessing disease activity in MS and NMOSD","volume":"17","author":"Li","year":"2024","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.cca.2025.120584_b0150","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1002\/glia.23480","article-title":"Glio- and neuro-protection by prosaposin is mediated by orphan G-protein coupled receptors GPR37L1 and GPR37","volume":"66","author":"Liu","year":"2018","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.cca.2025.120584_b0155","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12974-021-02249-1","article-title":"Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies","volume":"18","author":"Carnero Contentti","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.cca.2025.120584_b0160","doi-asserted-by":"crossref","unstructured":"M. Simons, E.M. Gibson, K.A. Nave, Oligodendrocytes: myelination, plasticity, and axonal support, Cold Spring Harb. Perspect. Biol. 16:a0413Published (2024) a041359. DOI: 10.1101\/cshperspect.a041359.","DOI":"10.1101\/cshperspect.a041359"},{"key":"10.1016\/j.cca.2025.120584_b0165","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/s41586-024-07853-8","article-title":"Oligodendrocytes and myelin limit neuronal plasticity in visual cortex","volume":"633","author":"Xin","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.cca.2025.120584_b0170","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1093\/brain\/awac307","article-title":"Oligodendrocyte progenitor cell recruitment and remyelination in multiple sclerosis: the more, the merrier?","volume":"145","author":"Tepav\u010devi\u0107","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.cca.2025.120584_b0175","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41593-021-01009-x","article-title":"New oligodendrocytes exhibit more abundant and accurate myelin regeneration than those that survive demyelination","volume":"25","author":"Neely","year":"2022","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.cca.2025.120584_b0180","doi-asserted-by":"crossref","first-page":"10116","DOI":"10.1038\/s41598-025-95000-2","article-title":"Pharmacological and resting state fMRI reveal osteocalcin\u2019s effects on mouse brain regions with high Gpr37 and Gpr158 expression","volume":"15","author":"Freus","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2025.120584_b0185","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1510666","article-title":"GPR37 and its neuroprotective mechanisms: bridging osteocalcin signaling and brain function","volume":"12","author":"Bian","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.cca.2025.120584_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113719","article-title":"GPR37 modulates progenitor cell dynamics in a mouse model of ischemic stroke","volume":"342","author":"Owino","year":"2021","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.cca.2025.120584_b0195","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.3390\/biomedicines10051006","article-title":"Osteocalcin alleviates lipopolysaccharide-induced acute inflammation via activation of GPR37 in Macrophages","volume":"10","author":"Qian","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.cca.2025.120584_b0200","doi-asserted-by":"crossref","first-page":"14426","DOI":"10.3390\/ijms232214426","article-title":"Inflammation and infection in pain and the role of GPR37","volume":"23","author":"Zhang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2025.120584_b0205","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1172\/JCI99888","article-title":"GPR37 regulates macrophage phagocytosis and resolution of inflammatory pain","volume":"128","author":"Bang","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2025.120584_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112808","article-title":"Efferocytes release extracellular vesicles to resolve inflammation and tissue injury via prosaposin-GPR37 signaling","volume":"42","author":"Bhattacharya","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.cca.2025.120584_b0215","article-title":"The role of orphan G protein-coupled receptors in pain","volume":"10","author":"Xu","year":"2024","journal-title":"Heliyon"},{"issue":"2","key":"10.1016\/j.cca.2025.120584_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115266","article-title":"Oligodendrocytes drive neuroinflammation and neurodegeneration in Parkinson's disease via the prosaposin-GPR37-IL-6 axis","volume":"44","author":"Ma","year":"2025","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.cca.2025.120584_b0225","doi-asserted-by":"crossref","first-page":"712","DOI":"10.15252\/embr.201643585","article-title":"Parkinson's disease-associated receptor GPR37 is an ER chaperone for LRP6","volume":"18","author":"Berger","year":"2017","journal-title":"EMBO Rep."},{"issue":"8","key":"10.1016\/j.cca.2025.120584_b0230","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1080\/14712598.2021.1884223","article-title":"Targeting the complement system in neuromyelitis optica spectrum disorder","volume":"21","author":"Asavapanumas","year":"2021","journal-title":"Expert Opin. Biol. Ther."},{"issue":"1","key":"10.1016\/j.cca.2025.120584_b0235","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00401-017-1734-6","article-title":"Bystander mechanism for complement-initiated early oligodendrocyte injury in neuromyelitis optica","volume":"134","author":"Tradtrantip","year":"2017","journal-title":"Acta Neuropathol."},{"issue":"9","key":"10.1016\/j.cca.2025.120584_b0240","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1016\/j.ymthe.2023.07.017","article-title":"Inhibition of complement C3 signaling ameliorates locomotor and visual dysfunction in autoimmune inflammatory diseases","volume":"31","author":"Xu","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.cca.2025.120584_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2024.102654","article-title":"Astrocyte-secreted C3 signaling impairs neuronal development and cognition in autoimmune diseases","volume":"240","author":"Zhu","year":"2024","journal-title":"Prog. Neurobiol."},{"issue":"5","key":"10.1016\/j.cca.2025.120584_b0250","doi-asserted-by":"crossref","DOI":"10.1172\/JCI141694","article-title":"Blood-brain barrier resealing in neuromyelitis optica occurs independently of astrocyte regeneration","volume":"131","author":"Winkler","year":"2021","journal-title":"J. Clin. Invest."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125004632?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125004632?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T19:48:23Z","timestamp":1772826503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898125004632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":50,"alternative-id":["S0009898125004632"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2025.120584","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum GPR37 as a novel biomarker for disease activity, disability, and differential diagnosis in NMOSD","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2025.120584","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120584"}}